Diagnostic and prognostic utility of Mastermind-like 2 (MAML2) gene rearrangement detection by fluorescent in situ hybridization (FISH) in mucoepidermoid carcinoma of the salivary glands

Peter P. Luk, James Wykes, Christina I. Selinger, Rafael Ekmejian, Jessica Tay, Kan Gao, Timothy J. Eviston, Trina Lum, Sandra A. O'Toole, Jonathan R. Clark, Ruta Gupta

Research output: Contribution to journalArticlepeer-review

Abstract

Objective Mucoepidermoid carcinoma (MEC) is the most common salivary gland malignancy, with a proportion harboring MAML2 rearrangement. This study evaluates the diagnostic and prognostic utility of MAML2 rearrangement in MEC. Study Design Salivary gland malignancies at a single institution (1989-2014) were reviewed to identify MECs. Histopathologic evaluation, immunohistochemistry, and fluorescent in situ hybridization (FISH) were performed. Results Forty-one cases of MEC were identified, with mean age of 47 years and mean tumor size of 21 mm. Seven locoregional recurrences and five MEC-related deaths were seen over a 22-year follow-up period. Thirty-eight cases were suitable for FISH, and 31 (82%) cases were positive for MAML2 rearrangement, including the oncocytic and clear cell variants of MEC. FISH was negative in the morphologic mimics of MEC. MAML2 rearrangement was significantly associated with longer survival. Conclusions MAML2 rearrangement is common and specific for MEC, which makes it a useful diagnostic tool. MAML2 rearrangement also predicts a favorable prognosis.
Original languageEnglish
Pages (from-to)530-541
Number of pages12
JournalOral Surgery , Oral Medicine , Oral Pathology and Oral Radiology
Volume121
Issue number5
DOIs
Publication statusPublished - 2016

Fingerprint

Dive into the research topics of 'Diagnostic and prognostic utility of Mastermind-like 2 (MAML2) gene rearrangement detection by fluorescent in situ hybridization (FISH) in mucoepidermoid carcinoma of the salivary glands'. Together they form a unique fingerprint.

Cite this